Additional file 2 of Expression of S100A8 protein on B cells is associated with disease activity in patients with systemic lupus erythematosus

Additional file 2: Supplementary Table 2. Detailed information of the registered patients. Detailed information of the SLE patients enrolled in the proteomics (LC-MSMS) and transcriptomics (DNA microarray) analysis. The samples of six patients were used for both proteomics and transcriptomics (SLE P1, P3, P5, P10, P11 and P14). *SLEDAI-2K ≥ 6 was defined as active. **Clinically diagnosed withoutrenal biopsy. Glucocorticoid dose was calculated as prednisolone-equivalent. AZA:azathioprine, MZB: mizoribine, RTX: rituximab.